Stocks by archetype
Every covered company is grouped by its latest published report archetype and valued on the methods that fit its economics. A bank is not a DCF; a hyper-grower is not a dividend stock. Pick an archetype to see how we frame it and what we watch for.
The archetypes
One company, one archetype. Classification decides which valuation methods carry weight and which questions the report leads with.
Revenue compounding far faster than the market can comfortably underwrite — valued on runway, not this quarter.
The picks-and-shovels of a secular build-out — fast-growing but more diversified and contract-backed than the apps on top.
High, durable returns on capital that compound without betting the company. Here the moat is the thesis.
Standard 9-phase methodology with archetype-specific valuation emphasis.
Earnings that rise and fall with a commodity, a capex cycle, or the economy. Normalize, don't extrapolate.
Deteriorated results, pessimistic price. The question is whether the decline is fixable or terminal.
Balance-sheet businesses whose product is risk. Valued on returns to equity and book, not free cash flow.
Not yet earning — the thesis is a path to profitability that must be argued, not observed.
Property income and asset value, not accounting earnings. Funds from operations, NAV, and the cost of debt.
Standard 9-phase methodology with archetype-specific valuation emphasis.